These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4326342)

  • 21. Mill Hill strain of parainfluenza 1 virus is a potent human interferon inducer.
    Martins RM; Rodriguez dos Santos J; Golgher RR
    J Interferon Res; 1989 Aug; 9(4):379-83. PubMed ID: 2474037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon production of human leukemic cells--an in-vitro assay.
    Yang SC; Hsia S
    Taiwan Yi Xue Hui Za Zhi; 1973 Nov; 72(11):612-8. PubMed ID: 4361244
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of cortisol on interferon production by mouse peritoneal leukocytes and spleen in vitro and in vivo.
    Mendelson J; Finland M
    Proc Soc Exp Biol Med; 1966 Oct; 123(1):98-104. PubMed ID: 4288628
    [No Abstract]   [Full Text] [Related]  

  • 24. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon.
    Preble OT; Rothko K; Klippel JH; Friedman RM; Johnston MI
    J Exp Med; 1983 Jun; 157(6):2140-6. PubMed ID: 6189954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Observations on production, assay and purification of chick embryo interferon.
    Cantell K; Valle M; Schakir R; Saukkonen JJ; Uroma E
    Ann Med Exp Biol Fenn; 1965; 43(3):125-31. PubMed ID: 4286218
    [No Abstract]   [Full Text] [Related]  

  • 26. Decreased interferon production by leukocytes in marasmus.
    Schlesinger L; Ohlbaum A; Grez L; Stekel A
    Am J Clin Nutr; 1976 Jul; 29(7):758-61. PubMed ID: 180790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-producing capacity of human tonsil cells and properties of interferon produced by these cells.
    Marchenko VI; Povolotsky YL; Krivokhatskaya LD
    Acta Virol; 1976 Apr; 20(2):114-8. PubMed ID: 5865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of the antiviral and antiproliferative activity of human interferon preparations obtained in suspension and stationary cultures of donor leukocytes].
    Timofeev IV; Kuznetsov VP; Mekhedov LN; Nikolaeva TG; Orlova TG
    Antibiotiki; 1981 Sep; 26(9):703-5. PubMed ID: 6170254
    [No Abstract]   [Full Text] [Related]  

  • 29. Production of interferon by long-term suspension cultures of leukocytes derived from patients with viral and nonviral diseases.
    Minnefor AB; Halsted CC; Seto DS; Glade PR; Moore GE; Carver DH
    J Infect Dis; 1970 Apr; 121(4):442-4. PubMed ID: 4315000
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cellular origin or rabbit serum interferon induced by Newcastle disease virus].
    Hellmann W; Kohlhage H
    Arch Gesamte Virusforsch; 1973; 40(3):334-40. PubMed ID: 4349398
    [No Abstract]   [Full Text] [Related]  

  • 31. Stability of human leukocyte interferon towards heat.
    Mogensen KE; Cantell K
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Jun; 81(3):382-3. PubMed ID: 4360140
    [No Abstract]   [Full Text] [Related]  

  • 32. Investigations on a tissue antagonist of interferon (TAI).
    Fournier F; Rousset S; Chany C
    Proc Soc Exp Biol Med; 1969 Dec; 132(3):943-50. PubMed ID: 4311845
    [No Abstract]   [Full Text] [Related]  

  • 33. Interferon induction by detoxicated bacterial endotoxins.
    Galabov AS; Galabov SM
    Acta Virol; 1973 Nov; 17(6):493-500. PubMed ID: 4150031
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of glycosylation inhibitors on the production and properties of human leukocyte interferon.
    Stewart WE; Wiranowska-Stewart M; Koistinen V; Cantell K
    Virology; 1979 Sep; 97(2):473-6. PubMed ID: 224593
    [No Abstract]   [Full Text] [Related]  

  • 35. Interference activity and sensitivity to interferon of original and "cold" strains of adenovirus types 1 and 2.
    Lysov VV; Aksenov OA; Rudenko VI; Moshkin SA; Yurlova TI; Smorodintsev AA; Selivanov AA
    Acta Virol; 1971 Sep; 15(5):387-92. PubMed ID: 4399137
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the suppression of cell and virus growth in transformed human cells of leukocyte and fibroblast interferon.
    Kuwata T; Fuse A; Suzuki N; Morinaga N
    J Gen Virol; 1979 May; 43(2):435-9. PubMed ID: 225426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that detergent-reactivated interferons are not renatured.
    Allen PT; Stewart WE
    J Gen Virol; 1976 Jul; 32(1):133-7. PubMed ID: 182910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon inhibitor in the blood of patients with systemic lupus erythematosus.
    Chadha KC; Ambrus JL; Stadler I; Ambrus JL
    J Biol Regul Homeost Agents; 1991; 5(1):1-9. PubMed ID: 1715634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired production of interferon in lymphocytes from immunosuppressed patients.
    Rytel MW; Balay J
    J Infect Dis; 1973 Apr; 127(4):445-9. PubMed ID: 4348498
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of butyrate on induction and action of interferon.
    Adolf GR; Swetly P
    Biochem Biophys Res Commun; 1981 Dec; 103(3):806-12. PubMed ID: 6174120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.